Skip to main content
SpringerLink
Log in

Vitamin D deficiency, insulin resistance, serum adipokine, and leptin levels in peritoneal dialysis patients

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Objective

Associations between 25 hydroxy vitamin D [25(OH)D], adipokines levels, and insulin resistance have been reported. The aim of this study was to explore the effects of cholecalciferol supplementation on vitamin D levels, insulin resistance, leptin, and adiponectin levels in vitamin D-deficient peritoneal dialysis (PD) patients.

Methods

In nineteen vitamin D-deficient PD patients, who were treated with cholecalciferol, fasting serum glucose, insulin, adiponectin, leptin, 25(OH)D and parathyroid hormone (PTH) were measured before and after cholecalciferol replacement therapy. Eighteen (94.7 %) PD patients with vitamin D deficiency were receiving active vitamin D compounds (alphacalciferol) for PTH control. Alphacalciferol dosing was kept constant during treatment with cholecalciferol.

Results

While mean 25(OH)D significantly increased from (10.2 ± 4.9 ng/ml) to (82.9 ± 56.5 ng/ml) (p < 0.05), mean homeostatic model assessment-insulin resistance index significantly decreased from (4.6 ± 3.6) to (2.8 ± 2.0) after cholecalciferol replacement therapy (p < 0.05). Serum leptin levels (12.9 ± 17.6 ng/ml) significantly increased (18.1 ± 19.5 ng/ml) (p < 0.05), while there was no change in serum adiponectin, calcium, and phosphate after vitamin D replacement. Serum PTH levels significantly decreased from 551.9 ± 276.6 pg/ml to 434.0 ± 273.4 ng/ml.

Conclusions

Cholecalciferol replacement therapy significantly decreases PTH levels and insulin resistance. The results of this study need to be confirmed in larger clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Shimada K, Miyazaki T, Daida H (2004) Adiponectin and atherosclerotic disease. Clin Chim Acta 344:1–12

    Article  PubMed  CAS  Google Scholar 

  2. Cnop M, Havel PJ, Utzschneider KM et al (2003) Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46:459–469

    PubMed  CAS  Google Scholar 

  3. Tschritter O, Fritsche A, Thamer C et al (2003) Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 52:239–243

    Article  PubMed  CAS  Google Scholar 

  4. Chen C, Chang YC, Liu CL, Liu TP, Chang KJ et al (2007) Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up- regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway. Endocr Relat Cancer 14:513–529

    Article  PubMed  CAS  Google Scholar 

  5. Hoda MR, Keely SJ, Bertelsen LS, Junger WG, Dharmasena D et al (2007) Leptin acts as a mitogenic and antiapoptotic factor for colonic cancer cells. Brit J Surg 94:346–354

    Article  PubMed  CAS  Google Scholar 

  6. Ahima RS, Saper CB, Flier JS, Elmquist JK (2000) Leptin regulation of neuroendocrine systems. Front Neuroendocrinol 21:263–307

    Article  PubMed  CAS  Google Scholar 

  7. Rodríguez-Carmona Ana, Fontán MiguelPérez, Cordido Fernando, Falcón TeresaGarcía, García-Buela Jesús (2000) Hyperleptinemia is not correlated with markers of protein malnutrition in chronic renal failure. Nephron 86:274–280

    Article  PubMed  Google Scholar 

  8. Huang JW, Yen CJ, Chiang HW, Hung KY, Tsai TJ, Wu KD (2004) Adiponectin in peritoneal dialysis patients: a comparison with hemodialysis patients and subjects with normal renal function. Am J Kidney Dis 43:1047–1055

    Article  PubMed  Google Scholar 

  9. Taskapan MC, Taskapan H, Sahin I, Keskin L, Atmaca H, Ozyalin F (2007) Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality. Ren Fail 29(2):147–154

    Article  PubMed  CAS  Google Scholar 

  10. Taskapan MC, Taskapan H, Sahin I, Keskin L, Atmaca H, Ozyalin F (2007) Relationship between insulin resistance and malondialdehyde levels in dialysis patients. Ren Fail 29(5):649–651

    Article  PubMed  CAS  Google Scholar 

  11. Lorente-Cebrián S, Eriksson A, Dunlop T, Mejhert N, Dahlman I, Aström G, Sjölin E, Wåhlén K, Carlberg C, Laurencikiene J, Hedén P, Arner P, Rydén M (2012) Differential effects of 1a,25-dihydroxycholecalciferol on MCP-1 and adiponectin production in human white adipocytes. Eur J Nutr 51(3):335–342

    Article  PubMed  Google Scholar 

  12. Menendez C, Lage M, Peino R, Baldelli R, Concheiro P et al (2001) Retinoic acid and vitamin D(3) powerfully inhibit in vitro leptin secretion by human adipose tissue. J Endocrinol 170:425–431

    Article  PubMed  CAS  Google Scholar 

  13. Reis JP, von Muhlen D, Kritz-Silverstein D, Wingard DL, Barrett-Connor E (2007) Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care 30:1549–1555

    Article  PubMed  CAS  Google Scholar 

  14. Vaidya A, Forman JP, Underwood PC et al (2011) The influence of body-mass index and renin-angiotensin-aldosterone system activity on the relationship between 25-hydroxyvitamin D and adiponectin in Caucasian men. Eur J Endocrinol 164:995–1002

    Article  PubMed  CAS  Google Scholar 

  15. Taskapan H, Ersoy FF, Passadakis P, Tam P, Memmos D, Katopodis K, Ozener C, Akcicek F, Camsarı T, Ates K, Ataman R, Vlachojannis JG, Dombros N, Utas C, Akpolat T, Bozfakioglu S, Wu GG, Karayaylali I, Arınsoy T, Stathakis Ch, Yavuz M, Tsakiris D, Dimitriades A, Yılmaz ME, Gultekin M, Karayalçin B, Polat N, Oreopoulos DG (2006) Severe vitamin D deficiency in chronic renal failure patients on peritoneal dialysis. Clin Nephrol Clin Nephrol 66(4):247–255

    CAS  Google Scholar 

  16. Taskapan H, Wei M, Oreopoulos DG (2006) 25(OH) Vitamin D(3) in patients with chronic kidney disease and those on dialysis: rediscovering its importance. Int Urol Nephrol 38(2):323–329

    Article  PubMed  CAS  Google Scholar 

  17. Taskapan H, Ersoy FF, Passadakis P, Tam P, Memmos D, Katopodis K, Ozener C, Akcicek F, Camsarı T, Ates K, Ataman R, Vlachojannis JG, Dombros N, Utas C, Akpolat T, Bozfakioglu S, Wu GG, Karayaylalı I, Arınsoy T, Stathakis Ch, Yavuz M, Tsakiris D, Dimitriades A, Yılmaz ME, Gultekin M, Karayalçin B, Polat N, Oreopoulos DG (2005) Body pain during daily activities in patients on peritoneal dialysis. Dial Transplant 2:58–72

    Google Scholar 

  18. Taskapan H (2012) Is 24,25(OH)D level really high in dialysis patients with high FGF23 levels? Int Urol Nephrol (Epub ahead of print)

  19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419

    Article  PubMed  CAS  Google Scholar 

  20. Bindal ME, Taskapan H (2011) Hypovitaminosis D and insulin resistance in peritoneal dialysis patients. Int Urol Nephrol 43(2):527–534

    Article  PubMed  CAS  Google Scholar 

  21. Chiu KC, Chu A, Go VL, Saad MF (2004) Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79(5):820–825

    PubMed  CAS  Google Scholar 

  22. Norman AW, Frankel JB, Heldt AM, Grodsky GM (1980) Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 209(4458):823–825

    Article  PubMed  CAS  Google Scholar 

  23. Inzucchi SE, Maggs DG, Spollett GR, Page SL, Rife FS, Walton V et al (1998) Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N Engl J Med 338(13):867–872

    Article  PubMed  CAS  Google Scholar 

  24. Kautzky-Willer A, Pacini G, Barnas U, Ludvik B, Streli C, Graf H, Prager R (1995) Intravenous calcitriol normalizes insulin sensitivity in uremic patients. Kidney Int 47(1):200–206

    Article  PubMed  CAS  Google Scholar 

  25. Gunal AI, Celiker H, Celebi H, Ustundağ B, Gunal SY (1997) Intravenous alfacalcidol improves insulin resistance in hemodialysis patients. Clin Nephrol 48(2):109–113

    PubMed  CAS  Google Scholar 

  26. Bonakdaran S, Ayatollahi H, Mojahedi MJ, Sharifipoor F, Shakeri M (2008) Impact of treatment with oral calcitriol on glucose intolerance and dyslipidemia(s) in hemodialysis patients. Saudi J Kidney Dis Transpl 19(6):942–947

    PubMed  Google Scholar 

  27. Maestro B, Davila N, Carranza MC, Calle C (2003) Identification of a Vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol 84:223–230

    Article  PubMed  CAS  Google Scholar 

  28. Maestro B, Campion J, Davila N, Calle C (2000) Stimulation by 1,25- dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J 47:383–391

    Article  PubMed  CAS  Google Scholar 

  29. Cohen-Lahav M, Douvdevani A, Chaimovitz C, Shany S (2007) The anti-inflammatory activity of 1,25-dihydroxyvitamin D3 in macrophages. J Steroid Biochem Mol Biol 103:558–562

    Article  PubMed  CAS  Google Scholar 

  30. Cantorna MT, Mahon BD (2005) D-hormone and the immune system. J Rheumatol Suppl 76:11–20

    PubMed  CAS  Google Scholar 

  31. Shoelson SE, Herrero L, Naaz A (2007) Obesity, inflammation, and insulin resistance. Gastroenterology 132:2169–2180

    Article  PubMed  CAS  Google Scholar 

  32. Gannagé-Yared MH, Chedid R, Khalife S et al (2009) Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young middle-eastern population. Eur J Endocrinol 160:965–971

    Article  PubMed  Google Scholar 

  33. Nimitphong H, Chanprasertyothin S, Jongjaroenprasert W, Ongphiphadhanakul B (2009) The association between vitamin D status and circulating adiponectin independent of adiposity in subjects with abnormal glucose tolerance. Endocrine 36:205–210

    Article  PubMed  CAS  Google Scholar 

  34. Vaidya A, Williams JS, Forman JP (2012) The independent association between 25-hydroxyvitamin D and adiponectin and its relation with BMI in two large cohorts: the NHS and the HPFS. Obesity (Silver Spring) 20(1):186

    Article  CAS  Google Scholar 

  35. Lee S, Lee DK, Choi E, Lee JW (2005) Identification of a functional vitamin D response element in the murine Insig-2 promoter and its potential role in the differentiation of 3T3–L1 preadipocytes. Mol Endocrinol 19:399–408

    Article  PubMed  CAS  Google Scholar 

  36. Kamei Y, Kawada T, Kazuki R, Ono T, Kato S, Sugimoto E (1993) Vitamin D receptor gene expression is up-regulated by 1, 25-dihydroxyvitamin D3 in 3T3–L1 preadipocytes. Biochem Biophys Res Commun 193:948–955

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by Inonu University Medical Research Center.

Author information

Authors and Affiliations

  1. Nephrology Department, Medical Faculty, Inonu University, Malatya, Turkey

    Ozkan Ulutas, Hulya Taskapan, Mehmet Cagatay Taskapan & Ismail Temel

  2. Biochemistry Department, Medical Faculty, Inonu University, Malatya, Turkey

    Ozkan Ulutas, Hulya Taskapan, Mehmet Cagatay Taskapan & Ismail Temel

Authors
  1. Ozkan Ulutas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hulya Taskapan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mehmet Cagatay Taskapan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ismail Temel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hulya Taskapan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ulutas, O., Taskapan, H., Taskapan, M.C. et al. Vitamin D deficiency, insulin resistance, serum adipokine, and leptin levels in peritoneal dialysis patients. Int Urol Nephrol 45, 879–884 (2013). https://doi.org/10.1007/s11255-012-0308-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-012-0308-8

Keywords

Search

Navigation